FDA-Drug2026-10-14Class IIPROCESSING DEFECT

Carolina Infusion tirzepatide/cyanocobalamin injection recalled for sterility assurance issues

OTHERNationwide distributionDrugsBaby & kids

What this means

Carolina Infusion, LLC is recalling tirzepatide/cyanocobalamin injectable medication due to lack of assurance of sterility. The issue relates to the formulation process using bacteriostatic water and processing equipment used to compound the product. The affected medication was distributed nationwide in patient-specific syringes.

  • Check if you received this injection from Carolina Infusion with a lot number and beyond-use date between 07/21/2026 and 08/29/2026.
  • Do not use the recalled medication. Contact your healthcare provider or pharmacy for guidance.
  • Return the medication to the pharmacy where you received it.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the U.S
Affected count
297 mL - in patient specific syringe dose
Manufactured in
95 Bees Creek Rd, N/A, Ridgeland, SC, United States
Products
TIRZEPATIDE/CYANOCOBALAMIN 26/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0027-2027

More Carolina Infusion recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.